Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Post-Marketing Surveillance of Statins—A Descriptive Analysis of Psychiatric Adverse Reactions in EudraVigilance
Gabriela Pop, Andreea Farcaș, Anca Butucă, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 12, pp. 1536-1536
Open Access | Times Cited: 17

Showing 17 citing articles:

Glucagon-like Peptide-1 Receptor Agonists and Suicidal Ideation: Analysis of Real-Word Data Collected in the European Pharmacovigilance Database
Rosanna Ruggiero, Annamaria Mascolo, Angela Spezzaferri, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 2, pp. 147-147
Open Access | Times Cited: 17
Statins—From Fungi to Pharmacy
Anna Sadowska, Patryk Osiński, Alicja Roztocka, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 466-466
Open Access | Times Cited: 22
Safety Profile of the Trastuzumab-Based ADCs: Analysis of Real-World Data Registered in EudraVigilance
Claudiu Morgovan, Carmen Maximiliana Dobrea, Anca Butucă, et al.
Biomedicines (2024) Vol. 12, Iss. 5, pp. 953-953
Open Access | Times Cited: 7
A Descriptive Analysis of Direct Oral Anticoagulant Drugs Dosing Errors Based on Spontaneous Reports from the EudraVigilance Database
Claudiu Morgovan, Carmen Maximiliana Dobrea, Adriana Aurelia Chiș, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 3, pp. 455-455
Open Access | Times Cited: 15
The Assessment of the Safety Profile of Selective Serotonin Reuptake Inhibitors Versus Other Antidepressants: Drug–Drug Interaction Insights from EudraVigilance
Carmen Maximiliana Dobrea, Claudiu Morgovan, Adina Frum, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1208-1208
Open Access
Real-World Evidence of Bevacizumab and Panitumumab Drug Resistance and Drug Ineffectiveness from EudraVigilance Database
Razvan Constantin Vonica, Claudiu Morgovan, Anca Butucă, et al.
Cancers (2025) Vol. 17, Iss. 4, pp. 663-663
Open Access
Bevacizumab—Insights from EudraVigilance Database on the Assessments of the Safety Profile of Monoclonal Antibodies Used as Targeted Cancer Treatment
Razvan Constantin Vonica, Anca Butucă, Claudiu Morgovan, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 4, pp. 501-501
Open Access
Drug–Drug Interactions of Selective Serotonin Reuptake Inhibitors: A Pharmacovigilance Study on Real-World Evidence from the EudraVigilance Database
Carmen Maximiliana Dobrea, Adina Frum, Anca Butucă, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 10, pp. 1278-1278
Open Access | Times Cited: 1
Real-Life Data on the Safety of Pasireotide in Acromegaly: Insights from EudraVigilance
Ioana Ilie, Carmen Maximiliana Dobrea, Anca Butucă, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 12, pp. 1631-1631
Open Access | Times Cited: 1
Advances in Research on Marine-Derived Lipid-Lowering Active Substances and Their Molecular Mechanisms
Lina Liu, Yihui Chen, Bei Chen, et al.
(2023)
Open Access | Times Cited: 3
An Update on Drug–Nutrient Interactions and Dental Decay in Older Adults
Victoria Bell, Ana Rita Rodrigues, Μαρία Αντωνιάδου, et al.
Nutrients (2023) Vol. 15, Iss. 23, pp. 4900-4900
Open Access | Times Cited: 3
Advances in Research on Marine-Derived Lipid-Lowering Active Substances and Their Molecular Mechanisms
Lina Liu, Yihui Chen, Bei Chen, et al.
Nutrients (2023) Vol. 15, Iss. 24, pp. 5118-5118
Open Access | Times Cited: 3
Safety Profiles Related to Dosing Errors of Rapid-Acting Insulin Analogs: A Comparative Analysis Using the EudraVigilance Database
Ioana Ilie, Andreea Loredana Vonica-Țincu, Carmen Maximiliana Dobrea, et al.
Biomedicines (2024) Vol. 12, Iss. 10, pp. 2273-2273
Open Access
Tremella fuciformis Berk Alleviated Atherosclerosis Symptoms via Nuclear Factor-Kappa B-Mediated Inflammatory Response in ApoE−/− Mice
Yihao Dong, Q. X. Zhang, Rui Xie, et al.
Nutrients (2024) Vol. 17, Iss. 1, pp. 160-160
Open Access
Level of implementation of the pharmacovigilance program and its associated factors in health institutions in Valle del Cauca
Jobany Castro Espinosa, Hernán Estupiñán Cabrera, María Antonieta Pineda, et al.
Revista Colombiana de Ciencias Químico Farmacéuticas (2024) Vol. 53, Iss. 2, pp. 488-512
Open Access
Pharmacology of dreaming
Oliver Bernath, Rania Ward
Somnologie - Schlafforschung und Schlafmedizin (2023) Vol. 27, Iss. 3, pp. 158-168
Closed Access | Times Cited: 1
Side effects of anti-lipid medications
Caitlin E. Kulig, Jessica Wilczynski, Jami Zajicek
Side effects of drugs annual (2023), pp. 427-442
Open Access | Times Cited: 1
New exploration of signal detection of Regional Risks from the perspective of data mining: a pharmacovigilance analysis based on spontaneous reporting data in Zhenjiang, China
Yuan Liu, Xiaoli Xu, Jingfei Yang, et al.
Expert Opinion on Drug Safety (2023) Vol. 23, Iss. 7, pp. 893-904
Closed Access
Page 1

Scroll to top